相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CrossTalk proposal: Ketone bodies are an important metabolic fuel for the heart
Qutuba G. Karwi et al.
JOURNAL OF PHYSIOLOGY-LONDON (2022)
Heart failure-emerging roles for the mitochondrial pyruvate carrier
Mariana Fernandez-Caggiano et al.
CELL DEATH AND DIFFERENTIATION (2021)
2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction A Report of the American College of Cardiology Solution Set Oversight Committee
Thomas M. Maddox et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
Cardiovascular disease (CVD): assessment, prediction and policy implications
Shazia Rehman et al.
BMC PUBLIC HEALTH (2021)
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
Stefan D. Anker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC)
Juhani Knuuti et al.
EUROPEAN HEART JOURNAL (2020)
Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019 Update From the GBD 2019 Study
Gregory A. Roth et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Mitochondrial pyruvate carrier abundance mediates pathological cardiac hypertrophy
Mariana Fernandez-Caggiano et al.
NATURE METABOLISM (2020)
Mechanisms of Cardiovascular Benefits of Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors A State-of-the-Art Review
Gary D. Lopaschuk et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2020)
SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart
Chenguang Li et al.
CARDIOVASCULAR DIABETOLOGY (2019)
Increased ketone body oxidation provides additional energy for the failing heart without improving cardiac efficiency
Kim L. Ho et al.
CARDIOVASCULAR RESEARCH (2019)
Neprilysin inhibition: a new therapeutic option for type 2 diabetes?
Nathalie Esser et al.
DIABETOLOGIA (2019)
Empagliflozin Ameliorates Adverse Left Ventricular Remodeling in Nondiabetic Heart Failure by Enhancing Myocardial Energetics
Carlos G. Santos-Gallego et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
V. Perkovic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
J. J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
S. D. Solomon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Use of fenofibrate on cardiovascular outcomes in statin users with metabolic syndrome: propensity matched cohort study
Nam Hoon Kim et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
Soren L. Kristensen et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
The Molecular Mechanism of Transport by the Mitochondrial ADP/ATP Carrier
Jonathan J. Ruprecht et al.
CELL (2019)
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
S. D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Malonyl CoA Decarboxylase Inhibition Improves Cardiac Function Post-Myocardial Infarction
Wei Wang et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2019)
Reactive oxygen species signalling in the diabetic heart: emerging prospect for therapeutic targeting
Adam J. Wilson et al.
HEART (2018)
Cardiovascular Metabolomics
Robert W. McGarrah et al.
CIRCULATION RESEARCH (2018)
Metabolic remodelling in heart failure
Edoardo Bertero et al.
NATURE REVIEWS CARDIOLOGY (2018)
ANGIOTENSIN II SIGNAL TRANSDUCTION: AN UPDATE ON MECHANISMS OF PHYSIOLOGY AND PATHOPHYSIOLOGY
Steven J. Forrester et al.
PHYSIOLOGICAL REVIEWS (2018)
ACE-inhibition induces a cardioprotective transcriptional response in the metabolic syndrome heart
Aziza Yakubova et al.
SCIENTIFIC REPORTS (2018)
Loss of Metabolic Flexibility in the Failing Heart
Qutuba G. Karwi et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2018)
Improved Insulin Sensitivity With Angiotensin Receptor Neprilysin Inhibition in Individuals With Obesity and Hypertension
J. Jordan et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
Neprilysin inhibition in heart failure: mechanisms and substrates beyond modulating natriuretic peptides
Emilia D'Elia et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
Impact of Oxidative Stress on the Heart and Vasculature Part 2 of a 3-Part Series
Thomas Muenzel et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Bruce Neal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Effect of sacubitril/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes: a post-hoc analysis from the PARADIGM-HF trial
Jelena P. Seferovic et al.
LANCET DIABETES & ENDOCRINOLOGY (2017)
Association of Fenofibrate Therapy With Long-term Cardiovascular Risk in Statin-Treated Patients With Type 2 Diabetes
Marshall B. Elam et al.
JAMA CARDIOLOGY (2017)
Circulating acylcarnitine profile in human heart failure: a surrogate of fatty acid metabolic dysregulation in mitochondria and beyond
Matthieu Ruiz et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2017)
Evidence for Intramyocardial Disruption of Lipid Metabolism and Increased Myocardial Ketone Utilization in Advanced Human Heart Failure
Kenneth C. Bedi et al.
CIRCULATION (2016)
Catabolic Defect of Branched-Chain Amino Acids Promotes Heart Failure
Haipeng Sun et al.
CIRCULATION (2016)
Evolving Concepts of Myocardial Energy Metabolism More Than Just Fats and Carbohydrates
Gary D. Lopaschuk et al.
CIRCULATION RESEARCH (2016)
Lipid Use and Misuse by the Heart
P. Christian Schulze et al.
CIRCULATION RESEARCH (2016)
Shift to Fatty Substrate Utilization in Response to Sodium-Glucose Cotransporter 2 Inhibition in Subjects Without Diabetes and Patients With Type 2 Diabetes
Ele Ferrannini et al.
DIABETES (2016)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Piotr Ponikowski et al.
EUROPEAN HEART JOURNAL (2016)
Heart failure: an historical perspective
Roberto Ferrari et al.
EUROPEAN HEART JOURNAL SUPPLEMENTS (2016)
The neprilysin pathway in heart failure: a review and guide on the use of sacubitril/valsartan
Pardeep S. Jhund et al.
HEART (2016)
Metabolic Staging in Human Heart Failure Circulating Acylcarnitines and the Failing Heart's Energetic Signature
J. Eduardo Rame
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Prognostic Implications of Long-Chain Acylcarnitines in Heart Failure and Reversibility With Mechanical Circulatory Support
Tariq Ahmad et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
The Effect of Trimetazidine Added to Pharmacological Treatment on All-Cause Mortality in Patients with Systolic Heart Failure
Stefan Grajek et al.
CARDIOLOGY (2015)
Metabolic Disturbances Identified in Plasma Are Associated With Outcomes in Patients With Heart Failure Diagnostic and Prognostic Value of Metabolomics
Mei-Ling Cheng et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Mitochondrial fatty acid oxidation alterations in heart failure, ischaemic heart disease and diabetic cardiomyopathy
N. Fillmore et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Metabolomic Analysis of Pressure-Overloaded and Infarcted Mouse Hearts
Brian E. Sansbury et al.
CIRCULATION-HEART FAILURE (2014)
Regulation and therapeutic strategies of 4-hydroxy-2-nonenal metabolism in heart disease
V. R. Mali et al.
FREE RADICAL RESEARCH (2014)
Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure
John J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
ANG II causes insulin resistance and induces cardiac metabolic switch and inefficiency: a critical role of PDK4
Jun Mori et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2013)
Targeting mitochondrial oxidative metabolism as an approach to treat heart failure
Natasha Fillmore et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)
Pressure-overload-induced heart failure induces a selective reduction in glucose oxidation at physiological afterload
Pavel Zhabyeyev et al.
CARDIOVASCULAR RESEARCH (2013)
Cardiac Metabolism in Heart Failure Implications Beyond ATP Production
Torsten Doenst et al.
CIRCULATION RESEARCH (2013)
Cardiac Insulin-Resistance and Decreased Mitochondrial Energy Production Precede the Development of Systolic Heart Failure After Pressure-Overload Hypertrophy
Liyan Zhang et al.
CIRCULATION-HEART FAILURE (2013)
Peak oxygen consumption and prognosis in heart failure 14 mL/kg/min is not a gender-neutral reference
Ugo Corra et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
HMDB 3.0-The Human Metabolome Database in 2013
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2013)
Correction: Aerobic Capacity Reference Data in 3816 Healthy Men and Women 20–90 Years
Henrik Loe et al.
PLoS One (2013)
Lipid Metabolism and Toxicity in the Heart
Ira J. Goldberg et al.
CELL METABOLISM (2012)
Redox Signaling in Cardiac Physiology and Pathology
Joseph R. Burgoyne et al.
CIRCULATION RESEARCH (2012)
AMP-Activated Protein Kinase Regulation and Biological Actions in the Heart
Vlad G. Zaha et al.
CIRCULATION RESEARCH (2012)
Agonist-Induced Hypertrophy and Diastolic Dysfunction Are Associated With Selective Reduction in Glucose Oxidation A Metabolic Contribution to Heart Failure With Normal Ejection Fraction
Jun Mori et al.
CIRCULATION-HEART FAILURE (2012)
Cardiac diacylglycerol accumulation in high fat-fed mice is associated with impaired insulin-stimulated glucose oxidation
Liyan Zhang et al.
CARDIOVASCULAR RESEARCH (2011)
Modulating fatty acid oxidation in heart failure
Vincenzo Lionetti et al.
CARDIOVASCULAR RESEARCH (2011)
Forecasting the Future of Cardiovascular Disease in the United States A Policy Statement From the American Heart Association
Paul A. Heidenreich et al.
CIRCULATION (2011)
Fatty acid omega-oxidation as a rescue pathway for fatty acid oxidation disorders in humans
Ronald J. A. Wanders et al.
FEBS JOURNAL (2011)
Parallel effects of β-adrenoceptor blockade on cardiac function and fatty acid oxidation in the diabetic heart: Confronting the maze
Vijay Sharma et al.
WORLD JOURNAL OF CARDIOLOGY (2011)
Beta-Blockers and Oxidative Stress in Patients with Heart Failure
Kazufumi Nakamura et al.
PHARMACEUTICALS (2011)
Lipotoxicity in the heart
Adam R. Wende et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2010)
Decreased rates of substrate oxidation ex vivo predict the onset of heart failure and contractile dysfunction in rats with pressure overload
Torsten Doenst et al.
CARDIOVASCULAR RESEARCH (2010)
The ACCORD Study Group. Effects of combination lipid therapy in type 2 diabetes mellitus.
Lukasz Januszkiewicz
KARDIOLOGIA POLSKA (2010)
Myocardial Fatty Acid Metabolism in Health and Disease
Gary D. Lopaschuk et al.
PHYSIOLOGICAL REVIEWS (2010)
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
Henry N. Ginsberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
The Randle cycle revisited: a new head for an old hat
Louis Hue et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
How mitochondria produce reactive oxygen species
Michael P. Murphy
BIOCHEMICAL JOURNAL (2009)
Metabolic remodelling of the failing heart: beneficial or detrimental?
Marc van Bilsen et al.
CARDIOVASCULAR RESEARCH (2009)
Domestication of the cardiac mitochondrion for energy conversion
Robert S. Balaban
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2009)
Metoprolol improves cardiac function and modulates cardiac metabolism in the streptozotocin-diabetic rat
Vijay Sharma et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Chronic Glucagon-Like Peptide-1 Infusion Sustains Left Ventricular Systolic Function and Prolongs Survival in the Spontaneously Hypertensive, Heart Failure-Prone Rat
Indu Poornima et al.
CIRCULATION-HEART FAILURE (2008)
The renin-angiotensin aldosterone system: Pathophysiological role and pharmacologic inhibition
Steven A. Atlas
JOURNAL OF MANAGED CARE PHARMACY (2007)
Metabolic mechanisms in heart failure
Houman Ashrafian et al.
CIRCULATION (2007)
Recruitment of compensatory pathways to sustain oxidative flux with reduced carnitine palmitoyltransferase I activity characterizes inefficiency in energy metabolism in hypertrophied hearts
Natalia Sorokina et al.
CIRCULATION (2007)
Mechanisms of disease - The failing heart - An engine out of fuel
Stefan Neubauer
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Myocardial energetics and efficiency - Current status of the noninvasive approach
Paul Knaapen et al.
CIRCULATION (2007)
Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system
Puja K. Mehta et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
Antioxidant activity of carvedilol in cardiovascular disease
Paresh Dandona et al.
JOURNAL OF HYPERTENSION (2007)
A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure
Gabriele Fragasso et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Abnormalities of whole body protein turnover, muscle metabolism and levels of metabolic hormones in patients with chronic heart failure
H. Norrelund et al.
JOURNAL OF INTERNAL MEDICINE (2006)
Transcriptional regulation of metabolism
B Desvergne et al.
PHYSIOLOGICAL REVIEWS (2006)
The role of natriuretic peptides in cardioprotection
T Nishikimi et al.
CARDIOVASCULAR RESEARCH (2006)
Metabolic and endothelial effects of trimetazidine on forearm skeletal muscle in patients with type 2 diabetes and ischemic cardiomyopathy
LD Monti et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2006)
Chutes and ladders: The search for protein kinases that act on AMPK
LA Witters et al.
TRENDS IN BIOCHEMICAL SCIENCES (2006)
Estrogen-related receptor α directs peroxisome proliferator-activated receptor at signaling in the transcriptional control of energy metabolism in cardiac and skeletal muscle
JM Huss et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
PKC-θ knockout mice are protected from fat-induced insulin resistance
JK Kim et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Reactive oxygen species and angiotensin II signaling in vascular cells - implications in cardiovascular disease
RM Touyz
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2004)
Is the failing heart energy starved? On using chemical energy to support cardiac function
JS Ingwall et al.
CIRCULATION RESEARCH (2004)
Mechanisms for increased glycolysis in the hypertrophied rat heart
L Nascimben et al.
HYPERTENSION (2004)
Malonyl coenzyme a decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation
JRB Dyck et al.
CIRCULATION RESEARCH (2004)
Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol, European Trial (COMET): randomised controlled trial
PA Poole-Wilson et al.
LANCET (2003)
4-Hydroxy-2-nonenal: a product and mediator of oxidative stress
K Uchida
PROGRESS IN LIPID RESEARCH (2003)
β-blockers in chronic heart failure
M Gheorghiade et al.
CIRCULATION (2003)
Anti-oxidative properties of beta-blockers and angiotensin-converting enzyme inhibitors in congestive heart failure
BSP Chin et al.
EUROPEAN JOURNAL OF HEART FAILURE (2003)
Reactive oxygen species in the vasculature - Molecular and cellular mechanisms
Y Taniyama et al.
HYPERTENSION (2003)
Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with 31P-SLOOP magnetic resonance spectroscopy
M Beer et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy
VG Dávila-Román et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Angiotensin II receptor antagonists role in arterial hypertension
R Hernandez-Hernandez et al.
JOURNAL OF HUMAN HYPERTENSION (2002)
Load-induced changes in vivo alter substrate fluxes and insulin responsiveness of rat heart in vitro
T Doenst et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2001)
Regulation of cardiac and skeletal muscle malonyl-CoA decarboxylase by fatty acids
ME Young et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2001)
Uncoupling protein 3 transcription is regulated by peroxisome proliferator-activated receptor α in the adult rodent heart
ME Young et al.
FASEB JOURNAL (2001)
Antioxidant properties of carvedilol and metoprolol in heart failure: A double-blind randomized controlled trial
M Arumanayagam et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2001)
Altered expression of proteins of metabolic regulation during remodeling of the left ventricle after myocardial infarction
A Remondino et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2000)
Improved energy homeostasis of the heart in the metabolic state of exercise
GW Goodwin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2000)
Unsaturated aldehydes including 4-OH-nonenal are elevated in patients with congestive heart failure
S Mak et al.
JOURNAL OF CARDIAC FAILURE (2000)
Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial - the Losartan Heart Failure Survival Study ELITE II
B Pitt et al.
LANCET (2000)
Cardiac fatty acid uptake and transport in health and disease
GJ van der Vusse et al.
CARDIOVASCULAR RESEARCH (2000)
分享论文
